These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7531999)

  • 1. Evidence that regression in keratoacanthoma is immunologically mediated: a comparison with squamous cell carcinoma.
    Patel A; Halliday GM; Cooke BE; Barnetson RS
    Br J Dermatol; 1994 Dec; 131(6):789-98. PubMed ID: 7531999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spontaneous regression of human melanoma/nonmelanoma skin cancer: association with infiltrating CD4+ T cells.
    Halliday GM; Patel A; Hunt MJ; Tefany FJ; Barnetson RS
    World J Surg; 1995; 19(3):352-8. PubMed ID: 7638987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD30+ cells in regressing keratoacanthoma and in non-keratoacanthomatous squamous cell carcinoma.
    Fernandez-Flores A
    Bratisl Lek Listy; 2008; 109(11):508-12. PubMed ID: 19205562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of immunosuppressive and immunomodulatory cells in keratoacanthoma and cutaneous squamous cell carcinoma.
    Kambayashi Y; Fujimura T; Aiba S
    Acta Derm Venereol; 2013 Nov; 93(6):663-8. PubMed ID: 23572151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune response to human keratoacanthoma.
    Flannery GR; Muller HK
    Br J Dermatol; 1979 Dec; 101(6):625-32. PubMed ID: 394758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Keratoacanthoma and Keratoacanthoma-Like Squamous Cell Carcinoma: Similar Morphology but Different Pathogenesis.
    Watanabe IC; Magalhães RF; de Moraes AM; Stelini RF; Cintra GF; Metze K; Cintra ML
    Medicine (Baltimore); 2015 Jun; 94(23):e934. PubMed ID: 26061320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical staining for desmogleins 1 and 2 in keratinocytic neoplasms with squamous phenotype: actinic keratosis, keratoacanthoma and squamous cell carcinoma of the skin.
    Krunic AL; Garrod DR; Madani S; Buchanan MD; Clark RE
    Br J Cancer; 1998 Apr; 77(8):1275-9. PubMed ID: 9579833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VCAM (CD-106) and ICAM (CD-54) adhesion molecules distinguish keratoacanthomas from cutaneous squamous cell carcinomas.
    Melendez ND; Smoller BR; Morgan M
    Mod Pathol; 2003 Jan; 16(1):8-13. PubMed ID: 12527707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glut-1 expression and in situ CD1a/CD57 immunologic deficit in keratoacanthoma and squamous cell carcinoma of immunocompetent patients.
    Cabibi D; Aragona F; Guarnotta C; Rodolico V; Zerilli M; Belmonte B; Schillaci L; Aragona F
    Appl Immunohistochem Mol Morphol; 2011 May; 19(3):239-45. PubMed ID: 21475039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of T cell stimulation by superantigen plus major histocompatibility complex class II molecules or by CD3 monoclonal antibody: costimulation by purified adhesion ligands VCAM-1, ICAM-1, but not ELAM-1.
    van Seventer GA; Newman W; Shimizu Y; Nutman TB; Tanaka Y; Horgan KJ; Gopal TV; Ennis E; O'Sullivan D; Grey H
    J Exp Med; 1991 Oct; 174(4):901-13. PubMed ID: 1717633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of oncostatin M expression in keratoacanthoma and squamous cell carcinoma.
    Tran TA; Ross JS; Sheehan CE; Carlson JA
    Mod Pathol; 2000 Apr; 13(4):427-32. PubMed ID: 10786810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The potential role of abnormal E-cadherin and alpha-, beta- and gamma-catenin immunoreactivity in the determination of the biological behaviour of keratoacanthoma.
    Papadavid E; Pignatelli M; Zakynthinos S; Krausz T; Chu AC
    Br J Dermatol; 2001 Oct; 145(4):582-9. PubMed ID: 11703284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible key role of granzyme B in keratoacanthoma regression.
    Batinac T; Zamolo G; Coklo M; Hadzisejdic I
    Med Hypotheses; 2006; 66(6):1129-32. PubMed ID: 16497444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased Fas ligand expression by T cells and tumour cells in the progression of actinic keratosis to squamous cell carcinoma.
    Satchell AC; Barnetson RS; Halliday GM
    Br J Dermatol; 2004 Jul; 151(1):42-9. PubMed ID: 15270871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The level of syndecan-1 expression is a distinguishing feature in behavior between keratoacanthoma and invasive cutaneous squamous cell carcinoma.
    Mukunyadzi P; Sanderson RD; Fan CY; Smoller BR
    Mod Pathol; 2002 Jan; 15(1):45-9. PubMed ID: 11796840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cases with a spontaneous regression of an infiltrating non-crateriform keratoacanthoma and squamous cell carcinoma with a keratoacanthoma-like component.
    Misago N; Takai T; Murata Y; Nagase K; Narisawa Y
    J Dermatol; 2014 May; 41(5):430-4. PubMed ID: 24628407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Keratoacanthomas have an immunosuppressive cytokine environment of increased IL-10 and decreased GM-CSF compared to squamous cell carcinomas.
    Lowes MA; Bishop GA; Cooke BE; Barnetson RS; Halliday GM
    Br J Cancer; 1999 Jul; 80(10):1501-5. PubMed ID: 10408389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of tumor cells in the modification of T lymphocytes activity--the expression of the early CD69+, CD71+ and the late CD25+, CD26+, HLA/DR+ activation markers on T CD4+ and CD8+ cells in squamous cell laryngeal carcinoma. Part I.
    Starska K; Głowacka E; Kulig A; Lewy-Trenda I; Bryś M; Lewkowicz P
    Folia Histochem Cytobiol; 2011; 49(4):579-92. PubMed ID: 22252752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silver-stained organizer regions and immunoglobulins in cutaneous keratoacanthomas and squamous cell carcinomas.
    Aroni K; Mastoraki A; Kyriazi E; Ioannidis E; Patsouris E
    Pathol Res Pract; 2007; 203(9):659-65. PubMed ID: 17673372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pattern of TGFbeta receptor 1 expression differs between kras-mutated keratoacanthomas and squamous cell carcinomas of the skin.
    Berger F; Geddert H; Faller G; Werner M; Dimmler A
    Pathol Res Pract; 2014 Sep; 210(9):596-602. PubMed ID: 24954139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.